C4 Therapeutics, Inc. Share Price
NASDAQ: CCCCHealthcare
Live C4 Therapeutics, Inc. Share Price Chart
O H L
C4 Therapeutics, Inc. Performance Overview
Days Range
▼
$3.43Low
$3.47High
Markets Today
| Previous Close | $3.42 |
|---|---|
| Open | $3.44 |
| Volume | 191,179 |
| Day's Range | $3.43 - $3.47 |
| 52W Range | $1.69 - $5.17 |
| Market Cap | $424.44 M |
Historical Performance
| 1M Returns | -18.30 |
|---|---|
| 3M Returns | -17.71 |
| 6M Returns | +26.95 |
| 1Y Returns | +2.86 |
| 5Y Returns | -93.16 |
| 10Y Returns | NA |
C4 Therapeutics, Inc. Fundamentals
| Market Cap | $424.44 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $35.95 M |
| ROE TTM | -0.44 |
| EPS TTM | $-1.00 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.71 |
| EBITDA | $-102.53 M |
| Profit Margin | -292.08 |
| Market Cap | $424.44 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $35.95 M |
| ROE TTM | -0.44 |
| EPS TTM | $-1.00 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.71 |
| EBITDA | $-102.53 M |
| Profit Margin | -292.08 |
C4 Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $7.24 M | $6.46 M | $11.23 M | $11.02 M | $6.15 M | $6.64 M |
| Gross Profit + | $7.24 M | $6.46 M | $11.23 M | $11.02 M | $6.15 M | $6.64 M |
| Operating Income | -$29.16 M | -$28.50 M | -$34.41 M | -$23.14 M | -$27.79 M | -$26.42 M |
| EBITDA | -$28.71 M | -$27.89 M | -$23.22 M | -$22.72 M | -$27.38 M | -$26.13 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $456.00 K | $615.00 K | $11.19 M | $428.00 K | $404.00 K | $292.00 K |
| Income Before Tax | -$26.32 M | -$26.02 M | -$32.17 M | -$20.36 M | -$25.13 M | -$23.64 M |
| Income Tax Expense | $0 | $0 | $0 | $121.00 K | $0 | $0 |
| Net Income + | -$26.32 M | -$26.02 M | -$32.17 M | -$20.49 M | -$25.13 M | -$23.64 M |
| Net Profit Margin | -363.66% | -402.6% | -286.43% | -185.97% | -408.47% | -355.9% |
C4 Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $7.00 K | $7.00 K | $7.00 K | $9.00 K | $10.00 K | $12.00 K |
| Reserve & Surplus | -$659.98 M | -$686.07 M | -$718.12 M | -$738.64 M | -$764.14 M | -$787.90 M |
| Non-Current Liabilities | $83.56 M | $78.01 M | $75.14 M | $69.46 M | $67.36 M | $63.89 M |
| Current Liabilities | $40.82 M | $44.46 M | $35.95 M | $33.03 M | $27.25 M | $48.25 M |
| Total Liabilities | $124.38 M | $122.46 M | $111.08 M | $102.49 M | $94.61 M | $112.14 M |
| Fixed Assets | $5.48 M | $5.54 M | $5.13 M | $4.74 M | $4.49 M | $4.15 M |
| Current Assets | $232.53 M | $224.73 M | $206.86 M | $258.11 M | $245.37 M | $262.90 M |
| Total Assets | $319.52 M | $296.53 M | $265.49 M | $359.07 M | $328.86 M | $359.40 M |
C4 Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$26.32 M | -$26.02 M | -$32.17 M | -$20.49 M | -$25.13 M | -$23.64 M |
| Operating Cash Flow | -$33.28 M | -$12.06 M | -$31.21 M | -$22.14 M | -$29.94 M | -$1.57 M |
| Investing Cash Flow | $29.13 M | $38.92 M | $4.09 M | -$80.73 M | $16.15 M | -$14.81 M |
| Financing Cash Flow | -$46.00 K | $0 | $7.77 M | $118.67 M | $462.00 K | $33.73 M |
| Change in Cash | -$4.21 M | $26.86 M | -$19.35 M | $15.79 M | -$13.33 M | $17.34 M |
C4 Therapeutics, Inc. Return Calculator
The C4 Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$691
Invested Amount$10,000
Est. Returns$-9,309
About C4 Therapeutics, Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
Popular Stocks
FAQs
What is the share price of C4 Therapeutics, Inc. today?
C4 Therapeutics, Inc. (CCCC) share price as of September 18, 2026 is $3.45. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of C4 Therapeutics, Inc.?
Yes, Indian Investors can invest in the C4 Therapeutics, Inc. (CCCC) Share by opening an international trading account with Angel One.
How can I purchase C4 Therapeutics, Inc. shares in India?
Purchasing C4 Therapeutics, Inc. (CCCC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying C4 Therapeutics, Inc. (CCCC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of C4 Therapeutics, Inc.?
Yes, you can purchase fractional shares of C4 Therapeutics, Inc. (CCCC) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of C4 Therapeutics, Inc.?
The market capitalization of C4 Therapeutics, Inc. on September 18, 2026, is $424.44 M.
In which sector C4 Therapeutics, Inc. belongs?
C4 Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in C4 Therapeutics, Inc. stocks?
In order to invest in C4 Therapeutics, Inc. (CCCC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
